A series of 3-(5-aryl-4H-pyrazol-3-yl)anthracen-10(9H)-ones were synthesized from anthracen-10(9H)-one (1) and studied for their in vitro antibacterial activity. Anthracen-10(9H)-one after Friedel crafts acetylation with acetyl chloride yielded 3-acetylanthracen-10(9H)-one (2) which on further reaction with substituted aromatic aldehydes in the presence of catalytic amount of sodium hydroxide in water and ethanol furnished the corresponding 3-(3-arylacryloyl)anthracen-10(9H)-ones (3a-g) as intermediate compounds, which on further reaction with hydrazine hydrate in absolute ethanol formed the title compounds 3-(5-aryl-4H-pyrazol-3-yl)anthracen-10(9H)-ones (4a-g). These compounds were characterized by elemental analysis, IR, Mass and 1 H-NMR spectral data. All the compounds were evaluated for their in vitro antibacterial activity against two gram positive strains (Bacillus subtilis and Staphylococcus aureus) and two gram negative strains (Escherichia coli and Pseudomonas aeruginosa) taking ciprofloxacin as a standard drug. Some of the compounds showed significant antibacterial activity.
Introduction
Inflammation is a protective response by the body towards cell injury. Cell injury may be due to necrosis of cells or tissue, the intrusion of microbes (such as viruses, fungus or bacteria), toxins, hypoxia, etc. Inflammatory process entails a series of events in which different mechanisms are involved. Generally, Infectious diseases are one of the foremost health tribulations of the world population. Undoubtedly, the rapid development of resistance to the existing antimicrobial drugs is the root cause of this global issue. This opens the gateway for the medicinal scientists for the development of novel antimicrobial drugs having different mechanism of action to combat the problem of multi-drug resistance [1] . In a wide variety of polyaromatic compounds, the anthracene nucleus possesses significant biological activities like antimicrobial [2] , antioxidant [3] , antipsoriatic [4] , analgesic [5] and MAO inhibitory activity [6] . Anthracene, one of the most important classes of organic and medicinal chemistry, has been considered to be pharmacologically very important nucleus, owing to the potent and broad spectrum activities of the several anthracene analogs like anthraquinone, anthranol, anthrone, dithranol or anthralin. Anthracene moiety is an important member of pharmaceutical, synthetic and biochemical industries. Anthracene is present as anthranol, anthralin, anthraquinone, anthrone in a large number of therapeutic agents, naturally occurring pigments, vitamins, enzymes and in some synthetic dyes. Anthracene nucleus is present as pharmacophore in a variety of medicinal agents like Doxorubicin, Daunorubicin, Mitoxanthrone, Ametantrone [7] , Epirubicin [8] , Sapurimycin, Pluramycin, Dynemycin, and pharmacognostic agents like Heterophyllin, Rubiadin, Pustuline, Damnacanthol, Soranjodiol [9] , Alizarin, Emodin, Rhein and Adriamycin [10] . On the other side pyrazole, a heterocyclic nucleus constitutes an important class displaying broad spectrum of biological activities and have been reported Figure 1 . enlisting some anthracene containing drugs available around the world.
Material and methods
The purity of all the synthesized compounds were checked by thin layer chromatography (TLC) on silica gel G as stationary phase and different solvent systems as mobile phase using iodine vapors as detecting agent. Melting points were determined by the Tempo melting point determination apparatus in open capillary tubes and are uncorrected. Elemental analyses were carried out on Carlo Erba1106 CHN Analyzer. Infrared spectra were recorded on Shimadzu 8000 FTIR Spectrophotometer in KBr phase. Proton NMR spectra were done on Bruker Avance II 400 NMR Spectrometer using tetramethyl silane as internal standard. Mass spectra of the synthesized compounds were carried out on API-4000 Quadrupole Mass Spectrometer using electro spray ionization (ESI) technique in positive ion mode. Chemical shifts are expressed as δ values (ppm).
Result and Discussion

Chemistry
The synthesis of the title compounds, 3-(5-aryl-4H-pyrazol-3-yl)anthracen-10(9H)-ones (4a-g) were achieved following the steps outlined in the Hydrazine hydrate then reacted with (3a-g) in the presence of in absolute ethanol to give (4a-g). All the compounds were obtained in good yield. These compounds were characterized on the basis of elemental and spectral analyses. IR spectra of each compound showed a band for C=N stretching, (heterocyclic) vibrations near 1640 cm -1 . The C=O stretching vibrations of anthracenone were observed in the range of 1715-1725 cm -1 . The C-H stretching vibrations for aromatic ring were observed in the range of 3000-3045 cm -1 whereas the absorption for aromatic C-H bending vibrations was observed below 900 cm -1 . In case of 1 H-NMR, the chemical shift value for the aromatic protons Ar-H was observed in the range of 8.10-7.00 δ (ppm) and appeared as multilet (m). The two aromatic anthracene protons (C-CH 2 -C) appeared as singlet (s) in the assigned value of 3.98-3.70 δ (ppm). Two heterocyclic protons (C-CH 2 -C) of the pyrazole nucleus absorbed at 1.95-1.52 δ (ppm) and appeared as singlet. All the title compounds showed [M+H] + of 100% intensity as the molecular ion peak. The results of elemental analyses were found in good conformity with the calculated values.
Antibacterial Activity
All the synthesized title compounds were screened for their in vitro antibacterial activity against two gram positive bacterial strains i.e., Bacillus subtilis (MTCC 121), Staphylococcus aureus (MTCC 96) and two gram negative i.e., Escherichia coli. (MTCC 40), Pseudomonas aeruginosa (MTCC 2453) respectively and their minimum inhibitory concentration (MIC) were determined. Most of the title compounds (4a-g) were found to be active against all the bacterial strains used in this study. However, they showed more activity against the gram positive than the gram negative bacterial strains. The minimum inhibitory concentration (MIC) of the title compounds were found to be 1.05-1.50 µM, 1.05-1.80 µM, 0.60-1.95 µM and 0.60-1.80 µM against B. subtilis (MTCC 121), S. aureus (MTCC 96), E. coli (MTCC 40), P. aeruginosa (MTCC 2453), respectively. Title compounds bearing disubstituted electron withdrawing groups like halogens and releasing groups like hydroxyl, methoxyl reported significant antibacterial profile. The reference standard ciprofloxacin inhibited Gram positive bacteria viz., S. aureus and B. subtilis at a MIC range of 0.90 µM whereas against Gram negative bacteria viz., E. coli and P. aeruginosa at a MIC of 0.45 µM respectively. The results of the MIC for the standard drug, ciprofloxacin, against the bacterial strains used were found to be within the range as reported in the literature .
Experimental
Chemistry
The purity of all the synthesized compounds were checked by thin layer chromatography (TLC) on silica gel G as stationary phase and different solvent systems as mobile phase using iodine vapors as detecting agent. Melting points were determined by the Tempo melting point determination apparatus in open capillary tubes and are uncorrected. Elemental analyses were carried out on Carlo Erba1106 CHN Analyzer. Infrared spectra were recorded on Shimadzu 8000 FTIR Spectrophotometer in KBr phase. Proton NMR spectra were done on Bruker Avance II 400 NMR Spectrometer using tetramethyl silane as internal standard. Mass spectra of the synthesized compounds were carried out on API-4000 Quadrupole Mass Spectrometer using electro spray ionization (ESI) technique in positive ion mode. 3-(3-arylacryloyl) anthracen-10(9H)-ones (3a-g) and 3-(5-aryl-4H-pyrazol-3-yl)anthracen-10(9H)-ones (4a-g) were prepared according to the procedure described below.
Synthesis of 3-acetylanthracen-10(9H)-one (2)
A solution of anhydrous acetyl chloride (0.01 mol) dissolved in anhydrous dichloromethane (5 ml) was added drop by drop with continues stirring to a clear solution of powdered anhydrous aluminium chloride (0.015 mol) in anhydrous dichloromethane (10 ml). Anthracen-10(9H)-one (1) (0.01 mol) dissolved in anhydrous dichloromethane (10 ml) was added to the reaction mixture and stirred at 0 o C by keeping an ice bath over a magnetic stirrer. The ice bath was removed after the complete addition of anthracen-10(9H)-one and solution was stirred for 8-10 hrs. at room temperature. To this solution, was added dilute HCl and stirred well. Organic layer was separated and dichloromethane was evaporated resulting 3-acetylanthracen-10(9H)-one (2) in a good yield [11] .
Synthesis of 3-(3-arylacryloyl)anthracen-10(9H)-ones (3a-g)
To the solution of sodium hydroxide in water and ethanol, was added 3-acetylanthracen-10(9H)-one (2) and kept over a magnetic stirrer for 20 min and stirred. While stirring, substituted benzaldehydes (0.01 mol) were slowly added to the flask and stirred for another 5-6 hrs. The reaction mixture was refluxed for an appropriate time. After the completion of reaction, stirrer was removed and mixture was kept whole night in a refrigerator. Next day, the solution was poured in to crushed ice and pH was adjusted to neutral. Crude 3-(3-arylacryloyl) anthracen-10(9H)-ones (3a-g) were thus precipitated out, filtered, washed and recrystallised with ethanol [12].
Synthesis of 3-(5-aryl-4H-pyrazol-3-yl)anthracen-10(9H)-ones (4a-g)
To the solution 3-(3-arylacryloyl)anthracen-10(9H)-ones (3a-g) (0.01 mol) in 25 ml of absolute ethanol was added a solution of Hydrazine hydrate (0.01 mol) in absolute ethanol (5ml). The reaction mixture was refluxed and magnetically stirred for 9-10 hrs. The progress of the reaction was monitored by TLC using hexane: ethyl acetate (8:2). After the completion of reaction, the reaction mixture was cooled to room temperature. Later on after sufficient cooling, the product was poured in to crushed ice or ice cold water and acidified with dilute acetic acid. The product (4a-g) so obtained was filtered, washed with distilled water and recrystallised using ethanol [13] . (5-(3,4-dimethoxyphenyl)-4H-pyrazol-3-yl) (5-(2,4-dihydroxyphenyl)-4H-pyrazol-3-yl) (4-hydroxy-3-methoxyphenyl)-4H-pyrazol-3 5-(4-hydroxy-3-ethoxyphenyl)-4H-pyrazol-3 
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Antibacterial Screening
All the title compounds (4a-g) were screened for their in vitro antibacterial activity against two gram positive strains, i.e., Bacillus subtilis (MTCC 121) and Staphylococcus aureus (MTCC 96) and two gram negative strains, i.e., Escherichia coli (MTCC 40) and Pseudomonas aeruginosa (MTCC 2453) respectively. Ciprofloxacin was used as the standard drug for the present study. Serial two fold dilution technique was used for the study of antibacterial activity A stock solution (32 µM) of all the title compounds and standard drug was prepared in dimethyl sulfoxide. The tested solutions were serially diluted to give concentrations of 5, 2.5, 1.25, 0.625, 0.312, 0.156, 0.078 µg/mL respectively which were later converted to µM concentrations. Sterilized double strength nutrient broth (DSNB) was used as a growth media. The stock solution was serially diluted by DSNB aseptically to give concentrations of 16 µM-0.25 µM into a series of sterilized culture tubes. All the tubes were inoculated by bacterial strain. The inoculum's size was approximately 10 6 colony forming units (CFU/ml). The inoculated tubes were incubated for 24 hrs. at 37 ± 1°C. After 24 hrs., the inoculated culture tubes were macroscopically examined for turbidity. The culture tube showing turbidity (lower concentration) and the culture tube showing no turbidity (higher concentration) gave the minimum inhibitory concentration (MIC) for the compound. The MIC for the title compounds and the standard ciprofloxacin are presented in Table 1 . was not found to inhibit the growth of any bacteria. Further studies are required to generate more information about structure activity relationship of these derivatives.
